Origins of Covid

Status
Not open for further replies.
IMHO it was bad bungling by the Chinese Government in the early stages rather then some evil plot.
The Chinses Government secrecy is a exercise in CYA more then anything else.
No one of significance is arguing evil plot. They are arguing covering up the lab error. And it's a no brainer, nothing to hide, no coverup. Being the country responsible for a worldwide deadly pandemic, intolerable, coverup would be mandatory. And the involvement of scientists outside China who were involved in some of the research is also intolerable to admit. Thus we get things like Fauci playing word games with gain or function research.

And there is a reason so many researchers are embracing a natural spillover. They are (whether they admit it to themselves or not) concerned about the public backlash that will encompass lab research around the world, involved in connected research or not. People will be outraged to find out COVID originated in a lab.
 
By accident I found another example, namely NPLLLKRRKKARALEAAA. KRRKK is five positively charged amino acids in a row. This is a portion of the sequence of the protein MAPKAPK2 and MAPKAPK3 has a nearly identical peptide sequence in this region. MAPKAPK2 stands for MAPK-activated protein kinases. These are signal transduction proteins, and I found these sequences and two more that have four positively charged residues in a row, in this paper Tanoue T et al., Nature Cell Biology 2(2):110-116 2000. PubMed
doi: 10.1038/35000065
EDT
My recollection is that this issue was raised because of a claim that having four positively charged amino acid residues in a row was impossible, or at the very least, never occurred in nature. K stands for lysine, and R stands for arginine; both amino acid residues have positively charged side chains. We can now be certain that having even four or five positively charged amino acid residues does occur in nature.
There are a lot of arguments about this and that being the smoking gun. One can take any one of those arguments and find a rebuttal.

Some may be more valid than others, some might not be valid at all. I can do the same thing with the natural spillover arguments. The latest one many people are latching onto is the Worobey study and it's being treated in the news media like it is the smoking gun.

His argument is based on patient proximity to the market but that can easily be explained by the fact the market was the location of a super-spreader event.

The claim A&B lineages represent two market spillover events is no stronger than those whose analysis show B is a variant of A and it had more transmissibility. The A lineage would still have been ready out of the box if it was the lab leak strain.

The strongest lab-leak origin argument based on certain unexpected findings in the genome is that of the furin cleavage site. Yes it can be found in distant coronaviruses in the wild and yes (IIRC) that was supposed to be the result of a recombination event.

As for coming from a pangolin coronavirus, there were no pangolins around the market, and none were found in the sarbecoronavirus subgenus. Many would argue not enough bat coronaviruses have been sampled.

But there are no other furin cleavage sites in the subgenus sarbecoronaviruses and it offers no benefit that it would be naturally selected in any SARS-like CoVs. It provides one of the stronger bits of evidence of human intervention in the evolution of SARS CoV2.

Could it be from a natural recombination event in the wild? Sure. Is it likely? No.

We are back to no smoking gun on either side and a lot of wannabe smoking guns that can each be argued against.


I'm waiting to hear the arguments against the HapMap/MOA studies which identified the early evolution of SARS CoV2 beginning more likely in Oct/Nov of 2019. That fits with other evidence like when the Chinese took their database of coronavirus genomes offline blocking public access. They wouldn't have done that if it had been a natural spillover event.

Have you looked at that research?
 
But there are no other furin cleavage sites in the subgenus sarbecoronaviruses and it offers no benefit that it would be naturally selected in any SARS-like CoVs. It provides one of the stronger bits of evidence of human intervention in the evolution of SARS CoV2.

Could it be from a natural recombination event in the wild? Sure. Is it likely? No.

A new paper has just been published that apparently shows how the FCS could have evolved naturally in SARS-CoV2.

https://www.nature.com/articles/s42003-022-03421-w.pdf

Also, I don’t understand your argument that an FCS “offers no benefit”. I mean the pandemic itself looks like perfectly good evidence for the benefit of FCS. It managed to replicate all over the world and ultimately that is the only “benefit” that matters to evolution.
 
As for the Top/Hap, I read the paper but don’t have any way to judge whether it is accurate or not. I have no knowledge of the field and have no way to assess the science.

The paper merely states that the likely emergence is somewhere between mid-September and early November. I mean, okay, we have to put it on the pile of papers that suggest various other times of emergence such as the Pekar paper that said it likely originated in November. Why or how am I to pick one over another?
 
IMHO it was bad bungling by the Chinese Government in the early stages rather then some evil plot.
The Chinses Government secrecy is a exercise in CYA more then anything else.

It was not even bungled all that badly from the details I've seen. Physicians see a lot of cases of pneumonia and even when it "looks different" they don't immediately jump to the conclusion it's caused by a completely new virus. The outbreak was identified in hospitals in the 3rd week of Jan from just a handful of cases and virus was isolated and sequenced in under 2 weeks from that point.

Originally I was swayed by the argument regional authorities dragged their feet a bit in raising an alert, but when you have 5 identified cases and no known deaths in a city of 10 million people causing a panic normally wouldn't have been a wise idea.

The problem is the stealth nature and high R value of covid. By the time you had 10 people in hospital and were still at zero known deaths (~Jan 20) there were probably 1000 people who had been infected. By the time you started to see a significant numbers of deaths in early Dec that was more like 25K and there was no hope of containing it. The result would have been the same anywhere IMO.
 
A new paper has just been published that apparently shows how the FCS could have evolved naturally in SARS-CoV2.

https://www.nature.com/articles/s42003-022-03421-w.pdf

Also, I don’t understand your argument that an FCS “offers no benefit”. I mean the pandemic itself looks like perfectly good evidence for the benefit of FCS. It managed to replicate all over the world and ultimately that is the only “benefit” that matters to evolution.

There is also the fact that we have found similar and even more advanced FCS in other wild Corona Viruses. Also worth reminding everyone that Covid only has a partial FCS rather than a full FCS which would have made it even more ineffective. If you were trying to make a human optimized Corona Virus you'd have used a full FCS not a partial FCS. It's also out of frame, which no lab would do.
 
As for the Top/Hap, I read the paper but don’t have any way to judge whether it is accurate or not. I have no knowledge of the field and have no way to assess the science.

The paper merely states that the likely emergence is somewhere between mid-September and early November. I mean, okay, we have to put it on the pile of papers that suggest various other times of emergence such as the Pekar paper that said it likely originated in November. Why or how am I to pick one over another?

If it jumped to earlier than Nov that early case numbers would have been much much higher in Dec unless it was limping along with very low Transmissibility for a month or so while it adapted to humans. This would undermine the argument that the virus was "ready to go" in humans and make the chances of it successfully making the jump very low.
 
A new paper has just been published that apparently shows how the FCS could have evolved naturally in SARS-CoV2.

https://www.nature.com/articles/s42003-022-03421-w.pdf

Also, I don’t understand your argument that an FCS “offers no benefit”. I mean the pandemic itself looks like perfectly good evidence for the benefit of FCS. It managed to replicate all over the world and ultimately that is the only “benefit” that matters to evolution.
That paper was submitted in Sept 2021 even if it was only recently published. It doesn't say anything new. It says the same thing, they showed that it's possible the FCS entered the horseshoe bat coronavirus genome naturally.

We know it could have evolved naturally. I said so. I said all the 'smoking gun wannabes' can be explained regardless of which theory of origin they are supposed to support.

As for a benefit to the organism, well yeah, think about what you said there: it has a great benefit in human infections. :cool:


You can pick apart any lab-leak evidence and I can pick apart any spillover evidence. That was the point of my post to Chris. You have to look at the bigger picture.

As for dueling battles over the significance of the FCS, this paper is of interest:
The Difficulty of Determining the Origin of the SARS-CoV-2 FCS
Jack Nunberg, whose group first inserted an S1/S2 FCS into the spike of SARS-CoV, said: “there is no way to know whether humans or nature inserted the site” in SARS-CoV-2 (Cyranoski 2020). ...

Whittaker recently (August 2021) published a comment describing the SARS-CoV-2 FCS as “highly unusual” (Whittaker 2021). Similar studies on MERS-CoV had also determined that its S1/S2 FCS is required for efficient entry into human lung and intestine cells, and influences the cell tropism of the virus (Park et al. 2016; Kleine-Weber et al. 2018). In September 2021, it was reported that an international group of scientists (including from the Wuhan Institute of Virology) had, in March 2018, proposed a roadmap for detecting novel proteolytic cleavage sites (including FCSs) in the spike sequences of novel sarbecoviruses and inserting these novel cleavage sites into the appropriate parental strain (Daszak 2018; Lerner and Hibbett 2021). ... The virologist David Baltimore commented that “these features make a powerful challenge to the idea of a natural origin for SARS2,” later clarifying that “you can't distinguish between the two origins from just looking at the sequence” (Caltech Weekly 2021).
That last bit was when the paper was taken as a smoking gun and it had to be clarified that it wasn't.

As more bat CoVs are sampled, it is possible that another SARSr-CoV will be discovered with an S1/S2 FCS insertion. FCSs have evolved naturally in other non-sarbecovirus families of betacoronaviruses (Wu and Zhao 2020). Therefore, an S1/S2 FCS emerging in a sarbecovirus is consistent with natural evolution. Even so, the knowledge that scientists had a workflow for identifying novel cleavage sites in diverse SARSr-CoVs and experimentally characterizing these cleavage sites in SARSr-CoVs—likely in a manner that makes the resulting recombinant SARSr-CoV practically indistinguishable from a rare SARSr-CoV with a naturally emerging FCS—makes it challenging to rule out an artificial origin of the SARS-CoV-2 S1/S2 FCS
So emergence naturally looks to be exceedingly rare if it occurs at all. While scientists had been working experimentally on inserting the FCS in SARS-like CoVs prior to the pandemic.
 
Last edited:
As for the Top/Hap, I read the paper but don’t have any way to judge whether it is accurate or not. I have no knowledge of the field and have no way to assess the science.

The paper merely states that the likely emergence is somewhere between mid-September and early November. I mean, okay, we have to put it on the pile of papers that suggest various other times of emergence such as the Pekar paper that said it likely originated in November. Why or how am I to pick one over another?

An earlier emergence pretty much makes Worobey's hypothesis unsupportable.

It fits with why the Chinese took the genome database down and also with the military games being the reason the virus showed up so early in Italy and the rest of Europe. I'm not sure why we haven't heard more about testing the attendees of the games for COVID. If none of them had COVID we should have heard that by now yet we haven't.

And it addresses the two lineages with B being a variant derived from A.
 
Too late to edit my posts but I referred to HapMap in a couple posts because I was reading articles in the technique that used that term. I should have been referring to TopHap.
 
That paper was submitted in Sept 2021 even if it was only recently published. It doesn't say anything new. It says the same thing, they showed that it's possible the FCS entered the horseshoe bat coronavirus genome naturally.

We know it could have evolved naturally. I said so. I said all the 'smoking gun wannabes' can be explained regardless of which theory of origin they are supposed to support.

As for a benefit to the organism, well yeah, think about what you said there: it has a great benefit in human infections. :cool:


You can pick apart any lab-leak evidence and I can pick apart any spillover evidence. That was the point of my post to Chris. You have to look at the bigger picture.

As for dueling battles over the significance of the FCS, this paper is of interest:
The Difficulty of Determining the Origin of the SARS-CoV-2 FCSThat last bit was when the paper was taken as a smoking gun and it had to be clarified that it wasn't.

So emergence naturally looks to be exceedingly rare if it occurs at all. While scientists had been working experimentally on inserting the FCS in SARS-like CoVs prior to the pandemic.

Can you stop using the words "smoking gun"? Nobody is using the term except you. The spillover argument does not rely on "smoking guns".
 
An earlier emergence pretty much makes Worobey's hypothesis unsupportable.

It fits with why the Chinese took the genome database down and also with the military games being the reason the virus showed up so early in Italy and the rest of Europe. I'm not sure why we haven't heard more about testing the attendees of the games for COVID. If none of them had COVID we should have heard that by now yet we haven't.

And it addresses the two lineages with B being a variant derived from A.

I don't think that is true. It could have emerged in the market in September and/or October and simply taken that long to become more transmissable.

Worobey's paper is based on epidemiology.

The paper that would be contradicted by the TopHap analysis is the Pekar paper.

But I have no way to judge whether the TopHap paper or the Pekar paper is more likely to be correct.

We should not just choose the paper based solely on which theory it fits better.

But as you say, it seems unusual if you could determine whether or not there were earlier outbreaks in the US or Italy without being able to blame Chinese obstructionism.

There seem to be a few possibilities, and one of those is simply that there was no pre-December spread to Italy (incidentally, that seems most parsimonious to me), but the theory most consistent with a lab leak, would have to then assume that Italy and/or the United States is involved in some kind of cover-up.

This is one of the reasons why, for me, it is difficult to posit a lab leak that doesn't also end up with ad hoc conspiracy theories being fashioned to paper over the cracks in the theory.
 
Can you stop using the words "smoking gun"? Nobody is using the term except you. The spillover argument does not rely on "smoking guns".
Sure if it bothers you. What term would you like to use for any piece of evidence that is conclusive?

I should probably go back to see what you used describing the Worobey study.
 
I don't think that is true. It could have emerged in the market in September and/or October and simply taken that long to become more transmissable.

Worobey's paper is based on epidemiology.

The paper that would be contradicted by the TopHap analysis is the Pekar paper.

But I have no way to judge whether the TopHap paper or the Pekar paper is more likely to be correct.
You are quite defensive of the Worobey paper. His study relies entirely on looking at how the cases cluster around the market. He ignores the fact earlier cases are not included.

We should not just choose the paper based solely on which theory it fits better.

But as you say, it seems unusual if you could determine whether or not there were earlier outbreaks in the US or Italy without being able to blame Chinese obstructionism.

There seem to be a few possibilities, and one of those is simply that there was no pre-December spread to Italy (incidentally, that seems most parsimonious to me), but the theory most consistent with a lab leak, would have to then assume that Italy and/or the United States is involved in some kind of cover-up.
You are way off base here.

This is one of the reasons why, for me, it is difficult to posit a lab leak that doesn't also end up with ad hoc conspiracy theories being fashioned to paper over the cracks in the theory.
No one is covering up early cases except the Chinese. Not sure where you are getting that. There are posts here with citations about early cases in Italy and some suspected early cases have been uncovered in the US.

Here's an example.
Reuters: Coronavirus came to Italy almost 6 months before the first official case, new study shows
COVID-19 was circulating in Italy from September 2019, according to a study by the Italian National Cancer Institute.
Italy’s first official COVID-19 case was detected on February 21st.
The new study which re-examined samples from a lung cancer screening trial between September 2019 and March 2020, suggests otherwise.
It showed that of the 959 healthy volunteers enrolled in the trial, 11% had developed coronavirus antibodies well before February.
A study by the University of Siena also supports this theory.
...

A further specific SARS-CoV-2 antibodies test was carried out by the University of Siena for the same research titled “Unexpected detection of SARS-CoV-2 antibodies in the pre-pandemic period in Italy”.

It showed that four cases dated back to the first week of October were also positive for antibodies neutralizing the virus, meaning they had got infected in September, Giovanni Apolone, a co-author of the study, told Reuters.
It would be interesting to see if this had any connection to the first cluster of cases in Italy in one city. I'll look into it.


As for the US, here's an example, also a Reuters article: Five U.S. states had coronavirus infections even before first reported cases -study
At least seven people in five U.S. states were infected with the novel coronavirus weeks before the states reported their first cases, a large new government study showed, pointing to the presence of the virus in the country as early as December 2019.

Participants who reported antibodies against SARS-CoV-2 were likely exposed to the virus at least several weeks before their sample was taken as the antibodies do not appear until about two weeks of infection, the researchers said.

The samples came from Illinois, Massachusetts, Mississippi, Pennsylvania and Wisconsin, and were part of a study of more than 24,000 samples taken for a National Institutes of Health research program between Jan. 2 and March 18, 2020....

Of the seven samples, three were from Illinois, where the first confirmed coronavirus case was reported on Jan. 24, while the remaining four states had one case each. Samples from participants in Illinois were collected on Jan. 7 and Massachusetts on Jan. 8.

These were not as early as the cases in Italy.
 
You are quite defensive of the Worobey paper. His study relies entirely on looking at how the cases cluster around the market. He ignores the fact earlier cases are not included.

I am not "defensive". I just try to be accurate. They do not "ignore" earlier cases. Rather they work with those cases they know about.

Which specific cases are being "ignored"?
 
September infections of Covid?

That makes no sense.

This has clearly not reached the level of established fact otherwise it would be part of any working theory of the origins of Covid.

Besides, if the cases were in September it would torpedo your claim the Wuhan Games led to the outbreaks in Italy.
 
As for the Top/Hap, I read the paper but don’t have any way to judge whether it is accurate or not. I have no knowledge of the field and have no way to assess the science.

The paper merely states that the likely emergence is somewhere between mid-September and early November. I mean, okay, we have to put it on the pile of papers that suggest various other times of emergence such as the Pekar paper that said it likely originated in November. Why or how am I to pick one over another?
All three of these papers were published in refereed journals:
  • Jonathan Pekar, Michael Worobey, Niema Moshiri, Konrad Scheffler, Joel O Wertheim. Timing the SARS-CoV-2 index case in Hubei province. Science 372(6540), pages 412-417, 18 March 2021. https://doi.org/10.1126/science.abf8003

  • Sudhir Kumar, Qiqing Tao, Steven Weaver, Maxwell Sanderford, Marcos A Caraballo-Ortiz, Sudip Sharma, Sergei L K Pond, Sayaka Miura. An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic. Molecular Biology and Evolution, 38(8), pages 3046-3059, August 2021. https://doi.org/10.1093/molbev/msab118

  • Marcos A Caraballo-Ortiz, Sayaka Miura, Maxwell Sanderford, Tenzin Dolker, Qiqing Tao, Steven Weaver, Sergei L K Pond, Sudhir Kumar. TopHap: rapid inference of key phylogenetic structures from common haplotypes in large genome collections with limited diversity. Bioinformatics 38(10), pages 2719-2726, 15 May 2022. https://doi.org/10.1093/bioinformatics/btac186
The papers were published in the order shown above. The second and third papers in that list refer to and cite all previous papers in that list. There is considerable overlap between the authors of the second and third papers in that list.

Allow me to suggest that all three papers should be regarded as credible, with each succeeding paper building upon and refining/improving the previous papers. That's how science usually works.

The paper that would be contradicted by the TopHap analysis is the Pekar paper.

But I have no way to judge whether the TopHap paper or the Pekar paper is more likely to be correct.
All three of these papers use statistical methods and simulations to infer the timing of variants. Caraballo-Ortiz published their paper more than a year after Pekar et al., so the Caraballo-Ortiz results are more recent and appear to use more sophisticated methods. It seems likely that the more recent papers improve upon the earlier one.


ETA:
September infections of Covid?

That makes no sense.

This has clearly not reached the level of established fact otherwise it would be part of any working theory of the origins of Covid.

Besides, if the cases were in September it would torpedo your claim the Wuhan Games led to the outbreaks in Italy.
On my reading of the paper by Caraballo-Ortiz et al., they are not suggesting any humans had been infected with SARS-CoV-2 in September 2019, or even in October. So far as I can tell, their methods are incapable of determining when the first human infections occurred. In the following quotation, they are talking about the evolution of the Most Recent Common Ancestor (MRCA) of SARS-CoV-2. With my highlighting:
Caraballo-Ortiz et al. said:
With a mutation rate range of 6.64 × 10−4 to 9.27 × 10−4 substitutions per site per year (Pekar et al., 2021), we can estimate that proCoV2 existed 7.7–10.8 weeks before the December 24, 2019 sampling date of Wuhan-1. This places the progenitor of SARS-CoV-2 to have evolved in mid-September to early-October 2019, many weeks earlier than the mid-November 2019 date proposed by Pekar et al. (2021).
 
Last edited:
I am not "defensive". I just try to be accurate. They do not "ignore" earlier cases. Rather they work with those cases they know about.
You put a lot of weight into Worobey's report because it's the main source of specific spillover evidence. But it really isn't any stronger than what we already know about the spillover hypothesis. There is still no animal source and no outbreaks anywhere else except Wuhan where these viruses were being studied and that included live cultures, a fact that I believe was denied at first. 'Of all the gin joints in China ...'

Which specific cases are being "ignored"?
The ones China at first admitted to then later refused to share any of the demographic data about. Demographic as in the things an epidemiologist would look at to track down the source of an outbreak.


Worobey used convenient confirmation bias data that was readily available. He ignored the rest. Quay used a similar approach noting that the hospitals taking COVID patients followed the metro line that connected the WIV to the city proper and you dismissed that analysis out of hand. Interestingly some of the the hospitals are near the market as well.

Wherever data was missing Worobey chalked it up to asymptomatic and mild cases. That's valid if you have dots to connect the cases. In Seattle and surroundings researchers at Fred Hutch (Bloom's lab) connected the dots between the first known patient who had come straight from Wuhan, to a Seattle resident that was picked up in a flu surveillance study, and to an outbreak at the nursing home near me. We don't know who passed the virus on in between, but the genetics showed the cases were connected.

Worobey concluded A&B lineages represented 2 separate spillover events both occurring at the seafood market. Other researchers think the A&B lineages have a direct connection with B being a variant of A.


Here's an example of fitting the evidence to existing bias: Paper by Worobey in Science: Dissecting the early COVID-19 cases in Wuhan

Samples from the earliest COVID-19 patients in Wuhan have been sequenced, and two distinct SARS-CoV-2 lineages, A and B, have been identified. Given that the elderly couple at HPHICWM was the WHO report’s cluster 1, it follows that the husband, illness onset 26 December (1), must be the source of the earliest lineage A sequence, Wuhan/IME-WH01/2019 (GenBank accession number MT291826) (see fig. S1), which he most likely got from his wife, who became ill 15 December. This raises the possibility that the Yangchahu Market that they visited may have been a site of a separate animal spillover.
Yes the earliest cases we have genome and other demographic data for. In the paper he uses the fact the hospital that had this patient was the first to identify the virus and raise the alarm. This was about the same time the Chinese had suppressed the ophthalmologist who reported seeing several cases of an unknown pneumonia in the hospital he worked in. So there were several cases in the hospitals that I didn't see Worobey addressing.

And he soon drops the other market as a spillover site:
However, the earliest known lineage A genomes have close geographical connections to Huanan Market: one from a patient (age and gender not reported) who stayed in a hotel near Huanan Market in the days before illness onset in December (15) and the other from the 62-year-old husband in cluster 1 who visited Yangchahu Market, just a few blocks north of Huanan Market (1), and lived just to the south (see the figure). Therefore, if lineage A had a separate animal origin from lineage B, both most likely occurred at Huanan Market, and the association with Yangchahu Market, which does not appear to have sold live mammals, is likely due to community transmission starting in the neighborhoods surrounding Huanan Market.
Sure, and coincidentally the Yangchahu market had not been cleared out and it could be tested. But it turns out there's no evidence there.

Maybe that's the other market the WHO report noted, IIRC they said a drain at another market had tested positive but the report doesn't name the market. This is the report a number of researchers claimed supported the conclusion spillovers occurred at multiple markets in Wuhan. I have asked numerous times in this thread to show us how the WHO report supported that conclusion. So far crickets. But I'm still open to someone finding it in the report.

The reason multiple market sources is important is it supposedly decreases the odds the virus coincidentally emerged where such viruses were being studied. Of all the gin joints in China ...

Getting back to Worobey:
Thus, 10 of these hospitals’ 19 earliest COVID-19 cases were linked to Huanan Market (∼53%), comparable both to Jinyintan’s 66% (of 41 cases) (4) and to the WHO-China report’s 33% of 168 retrospectively identified cases within Wuhan across December 2019 (1). ...

... there was a genuine preponderance of early COVID-19 cases associated with Huanan Market.
He goes on discussing how all the cases not connected to the market could have been infected by the virus circulating undetected.

Sure, but in addition, the cluster of cases could also be explained by a super-spreader event at the market.
 
Last edited:
Status
Not open for further replies.

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom